We will not keep your email address; we ask for it so your friend knows the email isn't spam.

You need to be signed in to access email alerts. If you have an account log in with your user name and password. If you don't have an account you can just enter your ...

and chronic inflammatory demyelinating polyneuropathy (CIDP), and as VYVGART SC or VYVDURA (Japan) for gMG in other regions globally. Efgartigimod SC is currently being evaluated in more than 15 ...

Digestive Issues: Acupuncture improves proper enzyme release, reduces inflammation, improves gut motility and repair, and reduces nausea. It aids in digestion and repair of several mechanisms.

Bexion Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company developing a novel class of biologic therapy to ...

Ania Turska is going through 'intensive' therapy to regain her ability to walk and talk, after being placed in a medically ...

A drug in advanced development for myasthenia gravis also showed promise as a treatment for primary Sjögren's syndrome, a ...

Your nervous system is a key force behind so many important bodily functions. But when your peripheral nerves—those found outside of the brain and spinal cord—are damaged, it can cause pain and ...

An Edinburgh woman is going through 'intensive' therapy to regain her ability to walk and talk, after being placed in a ...

Analysts appear optimistic for Intellia’s gene editor nex-z, which showed a greater serum TTR reduction than Alnylam’s ...

If you experience severe or sudden calf pain or suddenly have trouble moving or walking, it’s time to contact a healthcare ...

Intellia's Phase 3 trial for NTLA-2002 shows promise, but limitations warrant caution. See why we believe NTLA stock is hold ...